{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:33:22Z","timestamp":1790984002265,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2007,11,1]],"date-time":"2007-11-01T00:00:00Z","timestamp":1193875200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2007,11]]},"DOI":"10.1016\/j.jconrel.2007.08.007","type":"journal-article","created":{"date-parts":[[2007,8,17]],"date-time":"2007-08-17T07:08:24Z","timestamp":1187334504000},"page":"155-163","source":"Crossref","is-referenced-by-count":23,"title":["A newly developed oral heparin derivative for deep vein thrombosis: Non-human primate study"],"prefix":"10.1016","volume":"123","author":[{"given":"Sang Kyoon","family":"Kim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong Yun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Choong Yong","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong Hee","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyun Tae","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youngro","family":"Byun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2007.08.007_bib1","series-title":"Prevention of Venous Thyromboembolism","first-page":"69","author":"Landefiled","year":"1993"},{"key":"10.1016\/j.jconrel.2007.08.007_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0033-0620(94)80050-2","article-title":"Epidemiology and natural history of venous thromboembolism","volume":"36","author":"Alpert","year":"1994","journal-title":"Prog. Cardiovasc. Dis."},{"key":"10.1016\/j.jconrel.2007.08.007_bib3","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1056\/NEJM197910183011602","article-title":", Warfarin sodium versus low-dose heparin in the long-term treatment of venous thrombosis","volume":"301","author":"Hull","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2007.08.007_bib4","series-title":"Goodman and Gilman's The Pharmacological Basis of Therapeutics","first-page":"1343","author":"Majerus","year":"1996"},{"key":"10.1016\/j.jconrel.2007.08.007_bib5","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1161\/01.CIR.103.24.2994","article-title":"Guide to anticoagulant therapy: heparin","volume":"103","author":"Jack","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2007.08.007_bib6","doi-asserted-by":"crossref","first-page":"335S","DOI":"10.1378\/chest.108.4_Supplement.335S","article-title":"Antithrombotic therapy for venous thromboembolic disease","volume":"108","author":"Hyers","year":"1995","journal-title":"Chest"},{"key":"10.1016\/j.jconrel.2007.08.007_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1056\/NEJM198201283060401","article-title":"Adjusted subcutaneous heparin versus warfarin sodium in the long-term treatment of venous thrombosis","volume":"306","author":"Hull","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.jconrel.2007.08.007_bib8","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1161\/01.CIR.101.22.2658","article-title":"Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis","volume":"101","author":"Gonze","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2007.08.007_bib9","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/hc5001.100837","article-title":"Oral heparin prevents neointimal hyperplasia after arterial injury; Inhibitory potential depends on type of vascular injury","volume":"104","author":"Welt","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2007.08.007_bib10","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1161\/01.CIR.98.16.1610","article-title":"Oral delivery of anticoagulant doses of heparin; A randomized, double-blind, controlled study in humans","volume":"98","author":"Baughman","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2007.08.007_bib11","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jps.10097","article-title":"Anticoagulant activity of heparin following oral administration of heparin-loaded microparticles in rabbits","volume":"91","author":"Jiao","year":"2002","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.jconrel.2007.08.007_bib12","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jconrel.2006.03.020","article-title":"Oral bioavailability of a low molecular weight heparin using a polymeric delivery system","volume":"113","author":"Hoffart","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2007.08.007_bib13","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1023\/A:1019802310702","article-title":"Pathway of oral absorption of heparin with sodium N-(8-(2 hydroxybenzoyl)amino) caprylate","volume":"19","author":"Malkov","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.08.007_bib14","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/S0002-9610(98)00127-5","article-title":"Orally administered heparin for preventing deep venous thrombosis","volume":"176","author":"Mark","year":"1998","journal-title":"Am. J. Surg."},{"key":"10.1016\/j.jconrel.2007.08.007_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0049-3848(98)00124-8","article-title":"Preparation of slightly hydrophobic heparin derivatives which can be used for solvent casting in polymeric formulation","volume":"92","author":"Lee","year":"1998","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2007.08.007_bib16","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1161\/hc5001.100627","article-title":"Conjugation of low-molecular-weight heparin and deoxycholic acid for the development of a new oral anticoagulant agent","volume":"104","author":"Lee","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/j.jconrel.2007.08.007_bib17","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.thromres.2005.03.027","article-title":"Oral delivery of chemical conjugates of heparin and deoxycholic acid in aqueous formulation","volume":"117","author":"Kim","year":"2006","journal-title":"Thromb. Res."},{"key":"10.1016\/j.jconrel.2007.08.007_bib18","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.jconrel.2005.12.011","article-title":"Efficacy of orally active chemical conjugate of low molecular weight heparin and deoxycholic acid in rats, mice and monkeys","volume":"111","author":"Lee","year":"2006","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2007.08.007_bib19","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.jconrel.2007.03.008","article-title":"Absorption study of deoxycholic acid-heparin conjugate as a new form of oral anti-coagulant","volume":"120","author":"Kim","year":"2007","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2007.08.007_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1160\/TH06-02-0077","article-title":"Prevention effect of orally active heparin derivative on deep vein thrombosis","volume":"96","author":"Kim","year":"2006","journal-title":"Thromb. Haemost."},{"key":"10.1016\/j.jconrel.2007.08.007_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jconrel.2005.03.018","article-title":"Tricaprylin microemulsion for oral delivery of low molecular weight heparin conjugates","volume":"105","author":"Kim","year":"2005","journal-title":"J. Control. Release."},{"key":"10.1016\/j.jconrel.2007.08.007_bib22","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1023\/A:1026474919869","article-title":"Oral delivery of new heparin derivatives in rats","volume":"17","author":"Lee","year":"2000","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.08.007_bib23","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/00001721-199306000-00008","article-title":"Three stage chromogenic assay for the analysis of activation properties of factor X by cancer procoagulant","volume":"4","author":"Mielicki","year":"1993","journal-title":"Blood. Coagul. Fibrinol."},{"key":"10.1016\/j.jconrel.2007.08.007_bib24","first-page":"179","article-title":"The absolute oral bioavailability of selected drugs","volume":"27","author":"Sietsema","year":"1989","journal-title":"Int. J. Clin. Pharmacol. Ther. Toxicol."},{"key":"10.1016\/j.jconrel.2007.08.007_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1023\/A:1011544501243","article-title":"Commentary: The rate and extent of oral bioavailability vs. the rate and extent of oral absorption: classification and recommendation of terminology","volume":"28","author":"Win","year":"2001","journal-title":"J. Pharmacokinet. Phar."},{"key":"10.1016\/j.jconrel.2007.08.007_bib26","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1023\/A:1016169202830","article-title":"Comparison of oral absorption and bioavailability of drugs between monkey and human","volume":"19","author":"Win","year":"2002","journal-title":"Pharm. Res."},{"key":"10.1016\/j.jconrel.2007.08.007_bib27","first-page":"309","article-title":"Studies on the absorption, excretion and metabolism of DMSO in man","volume":"155","author":"Hucker","year":"1967","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.jconrel.2007.08.007_bib28","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/jf00107a049","article-title":"Natural occurring levels of dimethyl sulfoxide in selected fruits, vegetables, grains and beverages","volume":"29","author":"Pearson","year":"1981","journal-title":"J. Agr. Food. Chem."},{"key":"10.1016\/j.jconrel.2007.08.007_bib29","first-page":"243","article-title":"Biological actions of dimethyl sulfoxide","author":"Jacob","year":"1975","journal-title":"Annals New York Acad Sci."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365907004117?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365907004117?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,5,2]],"date-time":"2019-05-02T02:10:10Z","timestamp":1556763010000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365907004117"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,11]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,11]]}},"alternative-id":["S0168365907004117"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2007.08.007","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2007,11]]}}}